Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Call Transcript 2025

Oct 31, 2025

62616_rns_2025-10-31_367f04f5-2a73-43d4-983c-14dc55ee7776.pdf

Call Transcript

Open in viewer

Opens in your device viewer

October 31, 2025

BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E) Mumbai - 400 051

Scrip code: 532531

Symbol: STAR

Dear Madam/ Sirs,

Sub: Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30, 2025

Pursuant to Regulation 46 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the audio recording of Earnings Call held today i.e., Friday, October 31, 2025, at 16:30 Hrs IST for discussing unaudited financial results of the Company for the quarter and half year ended September 30, 2025, has been made available on our Company’s website at:

  • strides.com/audio/financial_results/annual_reports/earnings_call_transcript/2025 26/Q2FY26.mp3

Request you to take the same on record.

Thanks & Regards,

For Strides Pharma Science Limited,

Manjula R Company Secretary & Compliance Officer ICSI Membership No. A30515

Strides Pharma Science Limited CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 [email protected]; www.strides.com